Abstract | OBJECTIVE: METHODS: RESULTS: Mean age of participants was 23.8±13.7 years old. At baseline, mean total sleep time (hours) and ESS score were 12.9±0.3 and 17.8±1.4, respectively. Mean total sleep times after treatment were 9.1±0.7 and 8.5±1.0h at 4 and 8 treatment weeks, respectively. Mean ESS scores were 8.8±2.3 and 7.4±2.8 at 4 and 8 treatment weeks, respectively. One patient dropped out at the 2nd week due to poor effect. No adverse effects were noted. CONCLUSIONS:
|
Authors | Hideto Shinno, Ichiro Ishikawa, Mami Yamanaka, Ai Usui, Sonoko Danjo, Yasushi Inami, Jun Horiguchi, Yu Nakamura |
Journal | Sleep medicine
(Sleep Med)
Vol. 12
Issue 6
Pg. 578-83
(Jun 2011)
ISSN: 1878-5506 [Electronic] Netherlands |
PMID | 21570346
(Publication Type: Clinical Trial, Journal Article)
|
Copyright | Copyright © 2011 Elsevier B.V. All rights reserved. |
Chemical References |
|
Topics |
- Administration, Oral
- Adolescent
- Adult
- Female
- Humans
- Idiopathic Hypersomnia
(drug therapy)
- Male
- Middle Aged
- Polysomnography
- Prospective Studies
- Sleep
(drug effects)
- Sleep Stages
(drug effects)
- Thyroxine
(administration & dosage, adverse effects)
- Treatment Outcome
- Young Adult
|